Efficient Targeting of T Cell Malignancies In Vitro and In Vivo Using CD4-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells

被引：0
|
作者：
Pinz, Kevin G. [1 ]
Yakaboski, Elizabeth [1 ]
Jares, Alexander [2 ]
Liu, Hua [2 ]
Firor, Amelia E. [1 ]
Wada, Masayuki [1 ]
Leung, Lai-Han [3 ]
Jiang, Xun [1 ]
Ma, Yupo [2 ]
机构：
[1] ICell Gene Therapeut LLC, Stony Brook, NY USA
[2] Stony Brook Med, Pathol, Stony Brook, NY USA
[3] Macau Univ Sci & Technol, Inst Appl Res Med, Macau, Peoples R China
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33455-4
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
647
引用
收藏
页码：S256 / S257
页数：2
相关论文
共 50 条
  • [41] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [42] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [43] Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
    Chen, Long
    Chen, Fukun
    Niu, Huatao
    Li, Jindan
    Pu, Yongzhu
    Yang, Conghui
    Wang, Yue
    Huang, Rong
    Li, Ke
    Lei, Yujie
    Huang, Yunchao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] Chimeric Antigen Receptor (CAR) T-cell therapy; a promising outlook for refractory malignancies
    Haider, Syed Ali
    Tariq, Syed Maaz
    Hasan, Mohammad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (09) : 1422 - 1423
  • [45] Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells
    Fang, Karen Kai-Lin
    Lee, Jongbok
    Khatri, Ismat
    Na, Yoosu
    Zhang, Li
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
  • [46] Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch
    Ma, Gina
    Shen, Jiaqi
    Pinz, Kevin
    Wada, Masayuki
    Park, Jino
    Kim, Soojin
    Togano, Tomiteru
    Tse, William
    STEM CELL REVIEWS AND REPORTS, 2019, 15 (03) : 443 - 447
  • [47] Engineering chimeric antigen receptor (CAR) T cells for treatment of γδ T cell lymphomas
    Ellebrecht, C.
    Choi, E.
    Radaelli, E.
    Payne, A. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S81 - S81
  • [48] Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch
    Gina Ma
    Jiaqi Shen
    Kevin Pinz
    Masayuki Wada
    Jino Park
    Soojin Kim
    Tomiteru Togano
    William Tse
    Stem Cell Reviews and Reports, 2019, 15 : 443 - 447
  • [49] Chimeric antigen receptor T-cells for B-cell malignancies
    Lichtman, Eben I.
    Dotti, Gianpietro
    TRANSLATIONAL RESEARCH, 2017, 187 : 59 - 82
  • [50] Graded potency of chimeric antigen receptor (CAR)-engineered T cells for cancer immunotherapy.
    Sadelain, Michel
    Condomines, Maud
    Zhao, Zeguo
    Brentiens, Renier J.
    Riviera, Isabelle
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345